The autonomic nervous system and inflammatory bowel disease

Autonomic Neuroscience: Basic and Clinical

Volumn 133, Issue 1, 2007, Pages 104-114

  Taylor, Cormac T ^b   Keely, Stephen J ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Autonomic nervous system; Colitis; Enteric nervous system; Inflammatory bowel disease; Neuroimmune communication

Indexed keywords

ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; CELL COMMUNICATION; CHOLINERGIC SYSTEM; DISEASE COURSE; ENTERITIS; GLIA CELL; HUMAN; IMMUNE RESPONSE; INTESTINE FUNCTION; INTESTINE INNERVATION; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; HUMANS; INFLAMMATORY BOWEL DISEASES; NEUROIMMUNOMODULATION; NEUROSECRETORY SYSTEMS;

EID: 33947575354     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2006.11.005     Document Type: Review

References (122)

1. Araki T., and Milbrandt J. Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth. Neuron 17 (1996) 353-361
2. Aube A., Cherbut C., Barbier M., Xing J., Roze C., and Galmiche J. Altered myoelectrical activity in noninflamed ileum of rats with colitis induced by trinitrobenzene sulphonic acid. Neurogastroenterol. Motil. 11 (1999) 55-62
3. Aube A.-C., Cabarrocas J., Bauer J., Philippe D., Aubert P., Doulay F., Liblau R., Galmiche J.P., and Neunlist M. Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption. Gut 55 (2006) 630-637
4. Barrett K.E., and Keely S.J. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Ann. Rev. Physiol. 62 (2000) 535-572
5. Belai A., Boulos P., Robson T., and Burnstock G. Neurochemical coding in the small intestine of patients with Crohn's disease. Gut 40 (1997) 767-774
6. Bernstein C., and Vidrich A. Isolation, identification, and culture of normal mouse colonic glia. Glia 12 (1994) 108-116
7. Bernstein C.N., Walker J.R., and Graff L.A. On studying the connection between stress and IBD. Am. J. Gastroenterol. 101 (2006) 782-785
8. Bhatia V., and Tandon R. Stress and the gastrointestinal tract. J. Gastroenterol. Hepatol. 20 (2005) 332-339
9. Birrenbach T., and Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm. Bowel Dis. 10 (2004) 848-859
10. Bischoff S., and Gebhardt T. Role of mast cells and eosinophils in neuroimmune interactions regulating mucosal inflammation in inflammatory bowel disease. Adv. Exp. Med. Biol. 579 (2006) 177-208
11. Bjorck S., Jennische E., Dahlstrom A., and Ahlman H. Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats. Dig. Dis. Sci. V42 (1997) 824-832
12. Blandizzi C., Fornai M., Colucci R., Baschiera F., Barbara G., De Giorgio R., De Ponti F., Cristina Breschi M., and Del Tacca M. Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by [alpha]2-adrenoceptors in the presence of experimental colitis vol. 139 (2003) 309-320
13. Bongioanni P., Castagna M., and Morisi M. Immunohistochemical study of the enteric glia in chronic intestinal inflammatory disease. Minerva Med. 87 (1996) 323-329
14. Boyer L., Ghoreishi M., Templeman V., Vallance B.A., Buchan A.M., Jevon G., and Jacobson K. Myenteric plexus injury and apoptosis in experimental colitis. Autonom. Neurosci. 117 (2005) 41-53
15. Brandtzaeg P., Carlsen H., and Halstensen T. The B cell system in inflammatory bowel disease. Adv. Exp. Med. Biol. 579 (2006) 149-167
16. Braun A., Weibe P., Pfeufer A., Gessner R., and Renz H. Differential modulation of human immunoglobulin isotype production by the neuropeptides substance P, NKA and NKB. J. Neuroimmunol. 97 (1999) 43-50
17. Bubenik G. Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 10 (2001) 350-366
18. Bush T. Enteric glial cells. An upstream target for induction of necrotizing enterocolitis and Crohn's disease?. BioEssays 24 (2002) 130-140
19. Bush T.G., Savidge T.C., Freeman T.C., Cox H.J., Campbell E.A., Mucke L., Johnson M.H., and Sofroniew M.V. Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell 93 (1998) 189-201
20. Cabarrocas J., Savidge T., and Liblau R. Role of enteric glial cells in inflammatory bowel disease. Glia. 41 (2003) 81-93
21. Chamaillard M., Iacob R., Desreumaux P., and Colombel J. Advances and perspectives in the genetics of inflammatory bowel diseases. Clin. Gastroenterol. Hepatol. 4 (2006) 143-151
22. Coates M.D., Mahoney C.R., Linden D.R., Sampson J.E., Chen J., Blaszyk H., Crowell M.D., Sharkey K.A., Gershon M.D., Mawe G.M., and Moses P.L. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126 (2004) 1657-1664
23. Cooke H.J. Neuroimmune signaling in regulation of intestinal ion transport. Am. J. Physiol. Gastrointest. Liver Physiol. 266 (1994) G167-G178
24. Cooke H. Neurotransmitters in neuronal reflexes regulating intestinal secretion. Ann. N.Y. Acad. Sci. 915 (2000) 77-80
25. Cornet A., Savidge T.C., Cabarrocas J., Deng W.-L., Colombel J.-F., Lassmann H., Desreumaux P., and Liblau R.S. Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease?. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13306-13311
26. Corrao G., Tragnone A., Caprilli R., Trallori G., Papi C., Andreoi A., Di Paolo M., Riegler G., Rigo G.-P., Ferraù O., Mansi C., Ingrosso M., and valpiani D. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Int. J. Epidemiol. 27 (1998) 397-404
27. Crivellato E., Soldano F., and Travan L. A light and electron microscopic quantitative analysis of nerve-immune cell contacts in the gut-associated lymphoid tissue of the mouse colon. J. Submicrosc. Cytol. Pathol. 34 (2002) 55-66
28. Danese S., Sans M., and Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 3 (2004) 394-400
29. Davis D., Dockerty M., and Mayo C. The myenteric plexus in regional enteritis: a study of the number of ganglion cells in the ileum in 24 cases. Surg. Gynecol. Obstet. 101 (1955) 208-216
30. di Mola F.F., Friess H., Zhu Z.W., Koliopanos A., Bley T., Di Sebastiano P., Innocenti P., Zimmermann A., and Buchler M.W. Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut 46 (2000) 670-679
31. Durcan N., Costello R.W., McLean W.G., Blusztajn J., Madziar B., Fenech A.G., Hall I.P., Gleich G.J., McGarvey L., and Walsh M.-T. Eosinophil-mediated cholinergic nerve remodeling. Am. J. Respir. Cell Mol. Biol. 34 (2006) 775-786
32. Dvorak A.M., Osage J.E., Monahan R.A., and Dickerson G.R. Crohn's disease: transmission electron microscopic studies. III. Target tissues. Proliferation of and injury to smooth muscle and the autonomic nervous system. Hum. Pathol. 11 (1980) 620-634
33. El-Salhy M., Danielsson A., Stenling R., and Grimelius L. Colonic endocrine cells in inflammatory bowel disease. J. Intern. Med. 242 (1997) 413-419
34. Farhadi A., Keshavarzian A., Van de Kar L.D., Jakate S., Domm A., Zhang L., Shaikh M., Banan A., and Fields J.Z. Heightened responses to stressors in patients with inflammatory bowel disease. Am. J. Gastroenterol. 100 (2005) 1796-1804
35. Feher E., Altdorfer K., Bagameri G., and Feher J. Neuroimmune interactions in experimental colitis: an immunoelectron microscopic study. Neuroimmunomodulation 9 (2001) 247-255
36. Flemstrom G., and Sjoblom M. Epithelial cells and their neighbors. II. New perspectives on efferent signaling between brain, neuroendocrine cells, and gut epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G377-G380
37. Furlan R., Ardizzone S., Palazzolo L., Rimoldi A., Perego F., Barbic F., Bevilacqua M., Vago L., Porro G.B., and Malliani A. Sympathetic overactivity in active ulcerative colitis: effects of clonidine. Am. J. Physiol: Regul. Integr. Comp. Physiol. 290 (2006) R224-R232
38. Furness J.B. Types of neurons in the enteric nervous system. Journal of the Autonomic Nervous System 81 (2000) 87-96
39. Furness, J., Clerc, N., Vogalis F., Stebbing, M. 2003. The enteric nervous system and its extrinsic connections. In: Yamada T., Alpers D.N.K., Laine L., Owang C.,D. P. (Eds.), Textbook of Gastroenterology. 4th. Lippincott, Williams and Wilkins, Philadelphia, 12-34.
40. Gaudio E., Taddei G., Vetuschi A., Sferra R., Frieri G., Ricciardi G., and Caprilli R. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig. Dis. Sci. 44 (1999) 1458-1475
41. Geboes K., and Collins S. Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis. Neurogastroenterol. Motil. 10 (1998) 189-202
42. Geboes K., Rutgeerts P., Ectors N., Mebis J., Penninckx F., Vantrappen G., and Desmet V.J. Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology 103 (1992) 439-447
43. Goode T., O'Connell J., Anton P., Wong H., Reeve J., O'Sullivan G.C., Collins J.K., and Shanahan F. Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation. Gut 47 (2000) 387-396
44. Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Gut 51 (2002) 2i-5i
45. Grundy D. Signalling the state of the digestive tract. Autonom. Neurosci. 125 (2006) 76-80
46. Haller D. Intestinal epithelial cell signalling and host-derived negative regulators under chronic inflammation: to be or not to be activated determines the balance towards commensal bacteria. Neurogastroenterol. Motil. 18 (2006) 184-199
47. Hanauer S. Inflammatory bowel disease: epidemiology, pathogenesis and therapeutic opportunities. Inflamm. Bowel Dis. 12 (2006) S3-S9
48. Hansen M.B. The enteric nervous system I: organisation and classification. Pharmacol. Toxicol. 92 (2003) 105-113
49. Hart A., and Kamm M.A. Mechanisms of initiation and perpetuation of gut inflammation by stress. Aliment. Pharmacol. Ther. 16 (2002) 2017-2028
50. Hatoum O.A., Binion D.G., Otterson M.F., and Gutterman D.D. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 125 (2003) 58-69
51. Hollander D. Inflammatory bowel diseases and brain-gut axis. J. Pharm. Pharmacol. 54 (2003) 183-190
52. Jonsson M., Norrgard O., and Forsgren S. Substance P and the neurokinin-1 receptor in relation to eosinophilia in ulcerative colitis. Peptides 26 (2005) 799-814
53. Kasimay O., Guzel E., Gemici A., Abdyli A., Sulovari A., Ercan F., and Yegen B.C. Colitis-induced oxidative damage of the colon and skeletal muscle is ameliorated by regular exercise in rats: the anxiolytic role of exercise. Exp. Physiol. (2006) (Epub ahead of print)
54. Khan I., and Collins S. Expression of cytokines in the longitudinal muscle myenteric plexus of the inflamed intestine of rat. Gastroenterology 107 (1994) 691-700
55. Kimata H., and Fujimoto M. Vasoactive intestinal peptide specifically induces IgA1 and IgA2 production. Eur. J. Immunol. 24 (1994) 2262-2265
56. Kimball E.S., Wallace N.H., Schneider C.R., D'Andrea M.R., and Hornby P.J. Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice. Neurogastroenterol. Motil. 16 (2004) 811-818
57. Kyosola K., Penttila O., and Salaspuro M. Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand. J. Gastroenterol. 12 (1977) 363-367
58. Laird J.M.A., Olivar T., Lopez-Garcia J.A., Maggi C.A., and Cervero F. Responses of rat spinal neurons to distension of inflamed colon: role of tachykinin NK2 receptors. Neuropharmacology 40 (2001) 696-701
59. Lange S., and Delbro D.S. Adrenoceptor-mediated modulation of Evans blue dye permeation of rat small intestine. Dig. Dis. Sci. 40 (1995) 2623-2629
60. Li J., Norgard B., Precht D.H., and Olsen J. Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark. Am. J. Gastroenterol. 99 (2004) 1129-1133
61. Linden D.R., Couvrette J.M., Ciolino A., Mcquoid C., Blaszyk H., Sharkey K.A., and Mawe G.M. Indiscriminate loss of myenteric neurones in the TNBS-inflamed guinea-pig distal colon. Neurogastroenterol. Motil. 17 (2005) 751-760
62. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126 (2004) 1504-1517
63. Lomax A.E., Fernandez E., and Sharkey K.A. Plasticity of the enteric nervous system during intestinal inflammation. Neurogastroenterol. Motil. 17 (2005) 4-15
64. Lomax A.E., Linden D.R., Mawe G.M., and Sharkey K.A. Effects of gastrointestinal inflammation on enteroendocrine cells and enteric neural reflex circuits. Autonom. Neurosci. 126-127 (2006) 250-257
65. Longobardi T., Jacobs P., and Bernstein C.N. Work losses related to inflammatory bowel disease in the United States. Results from the National Health Interview Survey. Am. J. Gastroenterol. 98 (2003) 1064-1072
66. Mann S. Melatonin for ulcerative colitis?. Am. J. Gastroenterol. 98 (2003) 232-233
67. Mardini H., Kip K., and Wilson J. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig. Dis. Sci. 49 (2004) 492-497
68. Marteau P., Seksik P., and Shanahan F. Manipulation of the bacterial flora in inflammatory bowel disease. Best Pract. Res. Clin. Gastroenterol. 17 (2003) 47-61
69. Massa F., Marsicano G., Hermann H., Cannich A., Monory K., Cravatt B.F., Ferri G.-L., Sibaev A., Storr M., and Lutz B. The endogenous cannabinoid system protects against colonic inflammation. J. Clin. Invest. 113 (2004) 1202-1209
70. Mathew C.G., and Lewis C.M. Genetics of inflammatory bowel disease: progress and prospects. Hum. Mol. Genet. 13 (2004) R161-R168
71. Maunder R., and Esplen M. Supportive-expressive group psychotherapy for persons with inflammatory bowel disease. Can. J. Psychiatry 46 (2001) 622-626
72. Maunder R., Lancee W., Hunter J., Greenberg G., and Steinhart A. Attachment insecurity moderates the relationship between disease activity and depressive symptoms in ulcerative colitis. Inflamm. Bowel Dis. 11 (2005) 919-926
73. Maunder R., Greenberg G., Nolan R., Lancee W., Steinhart A., and Hunter J. Autonomic response to standardized stress predicts subsequent disease activity in ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 18 (2006) 413-420
74. Mawdsley J.E., and Rampton D.S. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 54 (2005) 1481-1491
75. Mawdsley J.E., Macey M.G., Feakins R.M., Langmead L., and Rampton D.S. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology 131 (2006) 410-419
76. McGrath J., McDonald J., and MacDonald J. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. (2004) (CD004722)
77. Miceli P.C., and Jacobson K. Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats. Autonom. Neurosci. 105 (2003) 16-24
78. Milde A., Arslan G., Overmier J., Berstad A., and Murison R. An acute stressor enhances sensitivity to a chemical irritant and increases 51CrEDTA permeability of the colon in adult rats. Integr. Physiol. Behav. Sci. 40 (2005) 35-44
79. Mittermaier C., Dejaco C., Waldhoer T., Oefferlbauer-Ernst A., Miehsler W., Beier M., Tillinger W., Gangl A., and Moser G. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom. Med. 66 (2004) 79-84
80. Mourad F.H., Barada K.A., Bou Rached N.A., Khoury C.I., Saade N.E., and Nassar C.F. Inhibitory effect of experimental colitis on fluid absorption in rat jejunum: role of the enteric nervous system, VIP, and nitric oxide. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G262-G268
81. Neunlist M., Aubert P., Toquet C., Oreshkova T., Barouk J., Lehur P.A., Schemann M., and Galmiche J.P. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut 52 (2003) 84-90
82. Neunlist M., Aubert P., Bonnaud S., Van Landeghem L., Coron E., Wedel T., Naveilhan P., Ruhl A., Lardeux B., Savidge T., Paris F., and Galmiche J.P. Enteric glia inhibits intestinal epithelial cell proliferation partly through a TGF-[beta]1-dependent pathway. Am. J. Physiol. Gastrointest. Liver Physiol. (2006) (Epub ahead of print)
83. O'Connor T., O'Connell J., O'Brien D., Goode T., Bredin C., and Shanahan F. The role of substance P in inflammatory disease. J. Cell. Physiol. 201 (2004) 167-180
84. Oshima S., Fujimura M., and Fukimiya M. Changes in number of serotonin-containing cells and serotonin levels in the intestinal mucosa of rats with colitis induced by dextran sodium sulfate. Histochem. Cell Biol. 112 (1999) 257-263
85. Pfeiffer C., Qiu B., and Lam S. Reduction of colonic mucus by repeated short-term stress enhances experimental colitis in rats. J. Physiol. 95 (2001) 81-87
86. Philippe D., Dubuquoy L., Groux H., Brun V., Chuoi-Mariot M.T.V., Gaveriaux-Ruff C., Colombel J.-F., Kieffer B.L., and Desreumaux P. Anti-inflammatory properties of the {micro} opioid receptor support its use in the treatment of colon inflammation. J. Clin. Invest. 111 (2003) 1329-1338
87. Qiu B., Vallance B., Blennerhassett P., and Collins S. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat. Med. 5 (1999) 1178-1182
88. Raithel M., Schneider H., and Hahn E. Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease. Scand. J. Gastroenterol. 34 (1999) 496-503
89. Raybould H.E., Cooke H.J., and Christofi F.L. Sensory mechanisms: transmitters, modulators and reflexes. Neurogastroenterol. Motil. 16 (2004) 60-63
90. Reber S.O., Obermeier F., Straub R.H., Falk W., and Neumann I.D. Chronic intermittent psycho-social stress in mice increases the severity of an acute DSS-induced colitis and additionally impairs regeneration. Endocrinology (2006) (EPub ahead of print)
91. Rindi G., Leitner A., Kopin A., Bordi C., and Solcia E. The "normal" endocrine cell of the gut: changing concepts and new evidences. Ann. N.Y. Acad. Sci. 1014 (2004) 1-12
92. Ruhl A. Glial regulation of neuronal plasticity in the gut: implications for clinicians. Gut 55 (2006) 600-602
93. Ruhl A., Franzke S., and Stremmel W. IL-1b and IL-10 have dual effects on enteric glial cell proliferation. Neurogastroenterol. Motil. 13 (2001) 89-94
94. Ruhl A., Nasser Y., and Sharkey K. Enteric glia. Neurogastroenterol. Motil. 16 (2004) 44-49
95. Sakamoto N., Kono S., Wakai K., Fukuda Y., Satomi M., Shimoyama T., Inaba Y., Miyake Y., Sasaki S., Okamoto K., Kobashi G., Washio M., Yokoyama T., Date C., and Tanaka H. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm. Bowel Dis. 11 (2005) 154-163
96. Sanovic S., Lamb D.P., and Blennerhassett M.G. Damage to the enteric nervous system in experimental colitis. Am. J. Pathol. 155 (1999) 1051-1057
97. Saruta M., Takahashi K., Suzuki T., Torii A., Kawakami M., and Sasano H. Urocortin 1 in colonic mucosa in patients with ulcerative colitis. J. Clin. Endocrinol. Metab. 89 (2004) 5352-5361
98. Saunders P.R., Miceli P., Vallance B.A., Wang L., Pinto S., Tougas G., Kamath M., and Jacobson K. Noradrenergic and cholinergic neural pathways mediate stress-induced reactivation of colitis in the rat. Autonom. Neurosci. 124 (2006) 56-68
99. Schafer K.-H., Mestres P., Marz P., and Rose-John S. The IL-6/sIL-6R fusion protein hyper-IL-6 promotes neurite outgrowth and neuron survival in cultured enteric neurons. J. Interferon Cytokine Res. 19 (1999) 527-532
100. Schmidt P., Ljung T., Hartmann B., Hare K., Holst J., and Hellström P. Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY. Eur. J. Gastroenterol. Hepatol. 17 (2005) 207-212
101. Schneider J., Jehle E.C., Starlinger M.J., Neunlist M., Michel K., Hoppe S., and Schemann M. Neurotransmitter coding of enteric neurones in the submucous plexus is changed in non-inflamed rectum of patients with Crohn's disease. Neurogastroenterol. Motil. 13 (2001) 255-264
102. Sharkey K.A., and Mawe G.M. Neuroimmune and epithelial interactions in intestinal inflammation. Curr. Opin. Pharm. 2 (2002) 669-677
103. Smith A.S., and Smid S.D. Impaired capsaicin and neurokinin-evoked colonic motility in inflammatory bowel disease. J. Gastroenterol. Hepatol. 20 (2005) 697-704
104. Sonea I.M., Palmer M.V., Akili D., and Harp J.A. Treatment with neurokinin-1 receptor antagonist reduces severity of inflammatory bowel disease induced by Cryptosporidium parvum. Clin. Diagn. Lab. Immunol. 9 (2002) 333-340
105. Stead R. Nerve remodelling during intestinal inflammation. Ann. N.Y. Acad. Sci. 664 (1992)
106. Steinkamp M., Geerling I., Seufferlein T., von Boyen G., Egger B., Grossmann J., Ludwig L., Adler G., and Reinshagen M. Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells. Gastroenterology 124 (2003) 1748-1757
107. Storsteen K., Kernohan J., and Bargen J. The myenteric plexus in chronic ulcerative colitis. Surg. Gynecol. Obstet. 97 (1953)
108. Stoyanova I., and Gulubova M. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Hisotochem. 104 (2002) 185-192
109. Thompson-Chagoyan O., Maldonado J., and Gil A. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response. Clin. Nutr. 24 (2005) 339-352
110. Tjwa E.T., Bradley J.M., Keenan C.M., Kroese A.B., and Sharkey K.A. Interleukin-1{beta} activates specific populations of enteric neurons and enteric glia in the guinea pig ileum and colon. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G1268-G1276
111. Todorovic V., Janic B., Koko V., Micev M., Nikoloc J., Ratkovic M., Leposavic G., Jankovic T., Knezevic-Usaj S., and Milicevic Z. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis - a radioimmunoassay and immunohisotchemical approach. Hepato-gastroenterol. 43 (1996) 483-488
112. Varghese A.K., Verdu E.F., Bercik P., Khan W.I., Blennerhassett P.A., Szechtman H., and Collins S.M. Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology 130 (2006) 1743-1753
113. Vasina V., Barbara G., Talamonti L., Stanghellini V., Corinaldesi R., Tonini M., De Ponti F., and De Giorgio R. Enteric neuroplasticity evoked by inflammation. Autonom. Neurosci. 126-127 (2006) 264-272
114. Velin A.K., Ericson A.-C., Braaf Y., Wallon C., and Soderholm J.D. Increased antigen and bacterial uptake in follicle associated epithelium induced by chronic psychological stress in rats. Gut 53 (2004) 494-500
115. Vermeire S., and Rutgeerts P. Current Status of Genetics Research in Inflammatory Bowel Disease (2005)
116. von Boyen G.B.T., Steinkamp M., Reinshagen M., Schafer K.-H., Adler G., and Kirsch J. Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut 53 (2004) 222-228
117. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., and Tracey K.J. Nicotinic acetylcholine receptor [alpha]7 subunit is an essential regulator of inflammation 421 (2003) 384-388
118. Watanabe T., Kubota Y., Sawada Y., and Muto Y. Distribution and quantification of somatostatin in inflammatory bowel disease. Dis. Colon Rectum. 35 (1992) 488-494
119. Williams R., Berthoud H., and Stead R. Vagal afferent nerve fibres contact mast cells in rat small intestinal mucosa. Neuroimmunomodulation 4 (1997) 266-270
120. Wittig B., and Zeitz M. The gut as an organ of immunology. International Journal of Colorectal Disease 18 (2003) 181-187
121. Wood J.D. Enteric neuroimmunophysiology and pathophysiology. Gastroenterology 127 (2004) 635-657
122. Yantiss R.K., and Odze R.D. Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology 48 (2006) 116-132